Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver resulting in approximately 800,000 deaths annually. A growing body of research investigating statin use and HCC risk has shown conflicting results. We aim to evaluate the current evidence of statin impact on HCC risk. We pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazaaleh, Shrouq, Sarmini, Muhammad Talal, Alomari, Mohammad, Al Momani, Laith, El Kurdi, Bara, Asfari, Mohammad, Almomani, Zain, Romero-Marrero, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Preventive Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388192/
https://www.ncbi.nlm.nih.gov/pubmed/35989795
http://dx.doi.org/10.7759/cureus.27032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388192/
https://www.ncbi.nlm.nih.gov/pubmed/35989795
http://dx.doi.org/10.7759/cureus.27032

Ejemplares similares